Novo Nordisk | NVO - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
ANI Pharmaceuticals USD 562.3M 21.58M 2026-03
Aurora Cannabis CAD 536.36M 30.74M 2025-12
Bausch Health Companies USD -2.06B 1.5B 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Canopy Growth CAD 758.17M 22.16M 2025-12
Corcept Therapeutics USD 637.99M 9.82M 2026-03
Drreddys Laboratories INR 4.14B 107.72M 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Merck USD 45.88B 6.73B 2026-03
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Novartis USD 38.93B 7.2B 2026-03
Novo Nordisk DKK 203.07B 9.02B 2026-03
Novo Nordisk DKK 26.56B 111.98B 2025-06
Pacira USD 653.89M 39.22M 2026-03
Perrigo USD 2.5B 436.7M 2026-03
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 1.89B 58.06M 2026-03
Sanofi EUR 72.81B 1.1B 2026-03
Supernus Pharmaceuticals USD 1.08B 15.09M 2026-03
Zoetis USD 3.23B 98M 2026-03